Suppr超能文献

用于高效诊断筛查高达1:100稀释度的混合鼻咽或唾液样本的快速严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒富集和RNA提取

Rapid SARS-CoV-2 Virus Enrichment and RNA Extraction for Efficient Diagnostic Screening of Pooled Nasopharyngeal or Saliva Samples for Dilutions Up to 1:100.

作者信息

Marshall Jamila S, Turiello Rachelle, Cunha Larissa L, Frazier Ella V, Hickey Jeff, Chapman Jeff, Poulter Melinda D, Fehling Heather L, Landers James P

机构信息

Department of Chemistry, University of Virginia, Charlottesville, VA 22904, USA.

MicroGEM International PLC, Charlottesville, VA 22903, USA.

出版信息

Diagnostics (Basel). 2022 Jun 6;12(6):1398. doi: 10.3390/diagnostics12061398.

Abstract

As COVID-19 transmission control measures are gradually being lifted, a sensitive and rapid diagnostic method for large-scale screening could prove essential for monitoring population infection rates. However, many rapid workflows for SARS-CoV-2 detection and diagnosis are not amenable to the analysis of large-volume samples. Previously, our group demonstrated a technique for SARS-CoV-2 nanoparticle-facilitated enrichment and enzymatic lysis from clinical samples in under 10 min. Here, this sample preparation strategy was applied to pooled samples originating from nasopharyngeal (NP) swabs eluted in viral transport medium (VTM) and saliva samples diluted up to 1:100. This preparation method was coupled with conventional RT-PCR on gold-standard instrumentation for proof-of-concept. Additionally, real-time PCR analysis was conducted using an in-house, ultra-rapid real-time microfluidic instrument paired with an experimentally optimized rapid protocol. Following pooling and extraction from clinical samples, average cycle threshold (C) values from resultant eluates generally increased as the pooling dilution factor increased; further, results from a double-blind study demonstrated 100% concordance with clinical values. In addition, preliminary data obtained from amplification of eluates prepared by this technique and analyzed using our portable, ultra-rapid real-time microfluidic PCR amplification instrument showed progress toward a streamlined method for rapid SARS-CoV-2 analysis from pooled samples.

摘要

随着新冠病毒传播控制措施逐渐解除,一种用于大规模筛查的灵敏且快速的诊断方法对于监测人群感染率可能至关重要。然而,许多用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测和诊断的快速工作流程并不适用于大量样本的分析。此前,我们团队展示了一种在不到10分钟的时间内从临床样本中实现SARS-CoV-2纳米颗粒辅助富集和酶解的技术。在此,这种样本制备策略被应用于源自用病毒运输培养基(VTM)洗脱的鼻咽(NP)拭子和稀释至1:100的唾液样本的混合样本。这种制备方法与在金标准仪器上进行的传统逆转录聚合酶链反应(RT-PCR)相结合,用于概念验证。此外,使用内部超快速实时微流控仪器并结合实验优化的快速方案进行实时PCR分析。从临床样本中进行混合和提取后,所得洗脱液的平均循环阈值(C)值通常随着混合稀释因子的增加而增加;此外,一项双盲研究的结果表明与临床值的一致性为100%。此外,使用我们的便携式超快速实时微流控PCR扩增仪器对通过该技术制备并分析的洗脱液进行扩增获得的初步数据显示,朝着从混合样本中快速分析SARS-CoV-2的简化方法取得了进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf4/9221879/ba07ce280c97/diagnostics-12-01398-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验